[Experimental substantiation of the use of cytokines in acute radiation disease].
In review of literature on experimental material the advantage of recombinant cytokine use is shown in acute radiation illness treatment. In review a number of tactical questions of cytokine therapy are interpreted: period and timing of medicines application, synergism and others.
Rogacheva
S A
SA
State Research Center of Russia, Institute of Biophysics, Ozyorsk Cheljabinsk Region.
D000208:Acute Disease; D000818:Animals; D002478:Cells, Cultured; D003115:Colony-Stimulating Factors / Q000494:pharmacology; D006224:Cricetinae; D016207:Cytokines / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D019583:Dose Fractionation, Radiation; D005346:Fibroblast Growth Factors / Q000494:pharmacology / Q000627:therapeutic use; D006168:Guinea Pigs; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D066298:In Vitro Techniques; D007378:Interleukins / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D011829:Radiation Dosage; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D051381:Rats; D013997:Time Factors
D003115:Colony-Stimulating Factors; D016207:Cytokines; D007378:Interleukins; D005346:Fibroblast Growth Factors